Digital Diabetes Management Market

Request for customization Inquire Before Buying

Digital Diabetes Management Market Size, Share and Industry Analysis Report By Product (Devices (Smart Glucose Meters, Continuous Glucose Monitoring (CGM) Systems, Smart Insulin Pens, Smart Insulin Pumps/Closed-loop Pumps & Smart Insulin Patches), Diabetes Apps, Service, Data Management Software); By Device Type (Handheld and Wearables); By End User (Hospitals & Self/home healthcare, Home Settings, Diagnostic Centers & Clinics and Academic & Research Institutes) - Forecast Year 2024 – 2031

Healthcare // Healthcare IT

Number of Pages: 226 Report Format: pdf Report ID: ZBA-379 Publishing Date: - September, 2022

Frequently Ask Question

The Global Digital Diabetes Management Market Is Forecasted To Grow At A Rate Of 13.2% To USD 31.33 Billion In 2029.

Key Factors That Are Driving The Market Growth Include Growing adoption of cloud-based enterprise solutions for diabetes management, Increasing prevalence of diabetes, Technological advancements

The Digital Diabetes Management Market Is Led By Devices Segment And Is Projected To Account For The Largest Size Of The Digital Diabetes Management Market From 2022 To 2029.

Some Key Players Operating In The Digital Diabetes Management Market Include Abbott Laboratories, Acon Laboratories, Inc., Agamatrix, Inc., Arkray, Inc., Ascensia Diabetes Care Holdings Ag, Azumio, B. Braun Melsungen Ag, Beato, Care Innovations, Llc, Dariohealth Corporation, Decide Clinical Software Gmbh, Dexcom, Inc., Dottli, Emperra Gmbh E-Health Technologies, F. Hoffmann-La Roche, Glooko, Inc., Health2Sync, Insulet Corporation, Lifescan, Inc., Medtronic Plc, One Drop, Pendiq Gmbh, Tandem Diabetes Care, Inc., Tidepool, Ypsomed Holding Ag